Rudolf T. Pillich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rudolf T. Pillich has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Alexander R. Pico
Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA
2 shared publications - Dexter Pratt
Department of Medicine, University of California San Diego, La Jolla, USA
2 shared publications - Trey Ideker
Program in Bioinformatics and Systems Biology, University of California, San Diego, La Jolla, USA
2 shared publications - Andreas Maier
University of Hamburg
1 shared publication Bm Gyori
Laboratory of Systems Pharmacology, Harvard Medical School
1 shared publication- Bruce Konicek
Eli Lilly and Company, Indianapolis, Indiana, USA
1 shared publication
Latest Publications
- Open Access
- 23 May 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (W1) , W481-W488
Drugst.One — a plug-and-play solution for online systems medicine and network-based drug repurposing
In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network medicine tools have emerged to identify potential drug repurposing candidates. However, these tools often require complex installation and lack intuitive visual network mining capabilities. To tackle these challenges, we introduce Drugst.One, a platform that assists specialized computational medicine tools in becoming user-friendly, web-based utilities for drug repurposing. With just three lines of code, Drugst.One turns any systems biology software into an interactive web tool for modeling and analyzing complex protein-drug-disease networks. Demonstrating its broad adaptability, Drugst.One has been successfully integrated with 21 computational systems medicine tools. Available at https://drugst.one, Drugst.One has significant potential for streamlining the drug discovery process, allowing researchers to focus on essential aspects of pharmaceutical treatment research.
- 23 May 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (W1) , W481-W488
Open AccessDrugst.One — a plug-and-play solution for online systems medicine and network-based drug repurposing
In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network medicine tools have emerged to identify potential drug repurposing candidates. However, these tools often require complex installation and lack intuitive visual network mining capabilities. To tackle these challenges, we introduce Drugst.One, a platform that assists specialized computational medicine tools in becoming user-friendly, web-based utilities for drug repurposing. With just three lines of code, Drugst.One turns any systems biology software into an interactive web tool for modeling and analyzing complex protein-drug-disease networks. Demonstrating its broad adaptability, Drugst.One has been successfully integrated with 21 computational systems medicine tools. Available at https://drugst.one, Drugst.One has significant potential for streamlining the drug discovery process, allowing researchers to focus on essential aspects of pharmaceutical treatment research.
- Open Access
State of the Interactomes: an evaluation of molecular networks for generating biological insights
Advancements in genomic and proteomic technologies have powered the use of gene and protein networks (“interactomes”) for understanding genotype-phenotype translation. However, the proliferation of interactomes complicates the selection of networks for specific applications. Here, we present a comprehensive evaluation of 46 current human interactomes, encompassing protein-protein interactions as well as gene regulatory, signaling, colocalization, and genetic interaction networks. Our analysis shows that large composite networks such as HumanNet, STRING, and FunCoup are most effective for identifying disease genes, while smaller networks such as DIP and SIGNOR demonstrate strong interaction prediction performance. These findings provide a benchmark for interactomes across diverse network biology applications and clarify factors that influence network performance. Furthermore, our evaluation pipeline paves the way for continued assessment of emerging and updated interaction networks in the future.
Open AccessState of the Interactomes: an evaluation of molecular networks for generating biological insights
Advancements in genomic and proteomic technologies have powered the use of gene and protein networks (“interactomes”) for understanding genotype-phenotype translation. However, the proliferation of interactomes complicates the selection of networks for specific applications. Here, we present a comprehensive evaluation of 46 current human interactomes, encompassing protein-protein interactions as well as gene regulatory, signaling, colocalization, and genetic interaction networks. Our analysis shows that large composite networks such as HumanNet, STRING, and FunCoup are most effective for identifying disease genes, while smaller networks such as DIP and SIGNOR demonstrate strong interaction prediction performance. These findings provide a benchmark for interactomes across diverse network biology applications and clarify factors that influence network performance. Furthermore, our evaluation pipeline paves the way for continued assessment of emerging and updated interaction networks in the future.
- Open Access
- 24 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (9) , 1689-1699
IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis
- 24 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (9) , 1689-1699
Open AccessIL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis
- Open Access
NDEx IQuery: a multi-method network gene set analysis leveraging the Network Data Exchange
Motivation The investigation of sets of genes using biological pathways is a common task for researchers and is supported by a wide variety of software tools. This type of analysis generates hypotheses about the biological processes active or modulated in a specific experimental context. Results The NDEx Integrated Query (IQuery) is a new tool for network and pathway-based gene set interpretation that complements or extends existing resources. It combines novel sources of pathways, integration with Cytoscape, and the ability to store and share analysis results. The IQuery web application performs multiple gene set analyses based on diverse pathways and networks stored in NDEx. These include curated pathways from WikiPathways and SIGNOR, published pathway figures from the last 27 years, machine-assembled networks using the INDRA system, and the new NCI-PID v2.0, an updated version of the popular NCI Pathway Interaction Database. IQuery’s integration with MSigDB and cBioPortal now provides pathway analysis in the context of these two resources. Availability and Implementation IQuery is available at https://www.ndexbio.org/iquery and is implemented in Javascript and Java. Contact Dexter Pratt ( depratt{at}health.ucsd.edu )
Open AccessNDEx IQuery: a multi-method network gene set analysis leveraging the Network Data Exchange
Motivation The investigation of sets of genes using biological pathways is a common task for researchers and is supported by a wide variety of software tools. This type of analysis generates hypotheses about the biological processes active or modulated in a specific experimental context. Results The NDEx Integrated Query (IQuery) is a new tool for network and pathway-based gene set interpretation that complements or extends existing resources. It combines novel sources of pathways, integration with Cytoscape, and the ability to store and share analysis results. The IQuery web application performs multiple gene set analyses based on diverse pathways and networks stored in NDEx. These include curated pathways from WikiPathways and SIGNOR, published pathway figures from the last 27 years, machine-assembled networks using the INDRA system, and the new NCI-PID v2.0, an updated version of the popular NCI Pathway Interaction Database. IQuery’s integration with MSigDB and cBioPortal now provides pathway analysis in the context of these two resources. Availability and Implementation IQuery is available at https://www.ndexbio.org/iquery and is implemented in Javascript and Java. Contact Dexter Pratt ( depratt{at}health.ucsd.edu )